Comparison of international guidelines for early-phase clinical trials of cellular and gene therapy products

Cellular and gene therapies (CGT) are promising fields that are bringing significant clinical benefits to patients by directly targeting the underlying cause of disease. In line with this trend, regulatory agencies in every country have been making efforts to accelerate CGT product development. For...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Wonsuk, Kim, Min-Gul, Kim, Anhye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979759/
https://www.ncbi.nlm.nih.gov/pubmed/35419313
http://dx.doi.org/10.12793/tcp.2022.30.e2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979759/
https://www.ncbi.nlm.nih.gov/pubmed/35419313
http://dx.doi.org/10.12793/tcp.2022.30.e2

Ejemplares similares